NEW YORK TRANSCATHETER VALVES SYPOSIUM

New York, NY
December 5, 2019

Target Audience

The New York Transcatheter Symposium 2019 has been designed to meet the educational needs of interventional cardiologists, invasive cardiologists, cardiac thoracic surgeons, interventional radiologists, nurses, technicians and allied health care professionals who work in structural heart disease.

Educational Goal

The goal is to provide cardiovas­cular specialists with the education they need to improve patient outcomes and reduce morbidity and mortality rates through the management of various conditions.

Learning Objectives

  • List new technologies in the management of structural heart disease
  • Explain indications, techniques, outcomes, and complications for transcatheter valve intervention in patients with native valve disease and bioprostectic valve dysfunction
  • Evaluate the rationale, challenges, and necessity of the heart team approach to valvular heart disease, and the functionality of the team within a center of excellence
  • Assess the barriers to care in patients with valvular heart disease with specific attention to current gaps in the timely delivery of percutaneous and surgical interventions

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Gaffney Events. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this live activity for a maximum of 8 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please complete the requirements for participation listed below.

Participation Requirements

  1. Complete sign in sheet
  2. Attend accredited sessions
  3. For credit log on to URL: https://online-med-edu.com/nytv2019 (you are here)
  4. Complete evaluation, credit request form, and download or print credit statement

Faculty and Disclosures

CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Alexandre Abizaid, MD, PhD, FACC
Director of Interventional Cardiology, Dante Pazzanese Institute of Cardiology
São Paulo, Brazil
Alexandre Abizaid has disclosed the following relevant financial relationship: Proctor-Boston Scientific

Anelechi C. Anyanwu, MD
Surgical Director, Mechanical Circulatory, Support and Heart Transplant Program
The Mount Sinai Hospital
New York, NY
Anelechi C. Anyanwu has no relevant financial relationships to disclose.

Antonio Colombo, MD
Director, Cardiac Catheterization Laboratory, EMO GVM Centro Cuore Columbus and San
Raffaele Hospital
Milano, MI
Antonio Colombo has no relevant financial relationships to disclose.

George D. Dangas, MD, PhD, FACC
Director, Cardiovascular Innovation, The Mount Sinai Hospital
New York, NY
George D. Dangas has disclosed the following relevant financial relationships: Boston Scientific, Abbott Vascular-Advisory Board, Spouse-Consultant

Eberhard Grube, MD
Head CIIC, University Hospital Bonn
Bonn, NRW
Eberhard Grube has disclosed the following relevant financial relationships: Cardiovalve, Equity, Ancora, MTEx-Advisory Board

Samir Kapadia, MD
Chairman, Department of CVM, Professor of Medicine, Director Sones Cardiac Catheterization Laboratories, Cleveland Clinic
Samir Kapadia has disclosed the following relevant financial relationships: Admedus-Medical Advisor

Saibal Kar, MD, FACC, FSCAI
Interventional Cardiologist, Center for Advanced Cardiac and Vascular Interventions
Los Angeles, CA
Saibal Kar has disclosed the following relevant financial relationships: Boston Scientific, Abbott Vascular, Medtronic-Consultant.

Sahil Khera, MD, MPH
Assistant Professor, Cardiology, Board Certified in Interventional Cardiology
The Mount Sinai Hospital
New York, NY
Sahil Khera has no relevant financial relationships to disclose.

Annapoorna S. Kini, MD, MRCP, FACC
Interventional Director, Structural Heart Program, The Mount Sinai Hospital
New York, NY
Annapoorna S. Kini has no relevant financial relationships to disclose.

Stamatios A. Lerakis, MD, PhD, FACC, FAHA
Director of Interventional Echocardiography and Imaging for Structural and Valve, The Mount Sinai Hospital
New York, NY
Stamatios A. Lerakis has no relevant financial relationships to disclose.

Barry A. Love, MD, FRCPC
Director, Congenital Cardiac Catheterization Laboratory, The Mount Sinai Hospital
New York, NY
Barry A. Love has disclosed the following relevant financial relationships: Edwards Lifesciences-Research Support

Raj Makkar, MD, FACC
Director, Interventional Cardiology and Cardiac Cath Lab, Cedars-Sinai Medical Center
Los Angeles, CA
Raj Makkar has disclosed the following relevant financial relationships: Cordis, Medtronic-Consultant; Abbott, Edwards Lifesciences-PI, research grants

Roxana Mehran, MD, FACC, FESC, MSCAI
Director of Interventional Cardiovascular, Research and Clinical Trials, Icahn School of Medicine at Mount Sinai, NY
Roxana Mehran has disclosed the following relevant financial relationships: Abbott, AstraZeneca, Bayer, Beth Israel Deaconess-Research Grants

Pedro R. Moreno, MD, FACC
Professor of Medicine, Cardiology, Director, Cardiac Cath Lab, Mount Sinai St. Luke’s
New York, NY
Pedro R. Moreno has disclosed the following relevant financial relationships: Abbott Vascular, Abiomed, Amgen-Honoraria

Rick A. Nishimura, MD
Professor of Cardiovascular Diseases and Hypertension, Chair, Division of Structural Heart Disease, Mayo Clinic
Rochester, MN
Rick A. Nishimura has no relevant financial relationships to disclose.

Gila Perk, MD
Director of Interventional Echocardiography, The Mount Sinai Hospital
New York, NY
Gila Perk has no relevant financial relationships to disclose.

Michael J. Reardon, MD
Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery, Professor of Cardiovascular Surgery, Institute for Academic Medicine, Full Member, Research Institute, Houston Methodist, Weill Cornell Medical College
Houston, TX
Michael J. Reardon has disclosed the following relevant financial relationships: Medtronic-Educational Speaker

Samin K. Sharma, MD, FACC, FSCAI
Director, Clinical & Interventional Cardiology, The Mount Sinai Hospital
New York, NY
Samin K. Sharma has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, and Cardiovascular Systems – Speaker’s Bureau

Gregg W. Stone, MD
Professor of Medicine and Population Health Sciences and Policy, The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai, Director of Academic Affairs, The Mount Sinai Health System, Co-Director of Medical Research and Education at the Cardiovascular Research Foundation
New York, NY
Gregg W. Stone has disclosed the following relevant financial relationships: Ancora, Neovasc, Gore, Balfix-Consultant

Rami Tadros, MD
Associate Program Director, Associate Professor of Surgery and Radiology, The Mount Sinai Hospital
New York, NY
Rami Tadros has no relevant financial relationship to disclose.

Gilbert H. Tang, MD, MSc, MBA, FACC
Surgical Director, Structural Heart Program,The Mount Sinai Hospital
New York, NY
Gilbert H. Tang has disclosed the following relevant financial relationships: Medtronic – Speaker Bureau, Consultant, Physician Proctor; Edwards Lifesciences – Physician Proctor; Abbott Structural Heart – Consultant, Faculty Trainer

Clyde Yancy, MD
Vice Dean, Diversity & Inclusion; Magerstadt Professor of Medicine; Professor of Medical Social, University Feinberg School of Medicine
Chicago, IL
Clyde Yancy has no relevant financial relationship to disclose.

Gian Paolo Ussia, MD
Associate Professor in Cardiology, University Campus Bio-Medico
Rome, Italy
Gian Paolo Ussia has no relevant financial relationships to disclose.

Mani A. Vannan, MD
Co-Chief Structural and Valvular Center of Excellence, Marcus Heart Valve Center, Piedmont Heart Institute
Atlanta, GA
Mani A. Vannan has disclosed the following relevant financial relationships: Siemens, Abbott, Medtronic-Advisory Board

Planner Disclosures

No member of CMEsolutions or Gaffney Events has any relevant financial relationships to disclose in regards to this activity.

Off-label Use

New York Transcatheter Symposium 2019 may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for this educational activity is provided by:
Boston Scientific Corporation
Abbott Laboratories

Fees

There are registration fees associated with this symposium as outlined on the website.

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy:  www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org.

 

 complete evaluation/credit request